|
1
|
Kashihara N, Haruna Y, Kondeti VK and
Kanwar YS: Oxidative stress in diabetic nephropathy. Curr Med Chem.
17:4256–4269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yokoyama H, Araki S, Kawai K, Hirao K,
Oishi M, Sugimoto K, Sone H, Maegawa H and Kashiwagi A; Japan
Diabetes Clinical Data Management Study Group: Pioglitazone
treatment and cardiovascular event and death in subjects with type
2 diabetes without established cardiovascular disease (JDDM 36).
Diabetes Res Clin Pract. 109:485–492. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ritz E: Diabetic nephropathy. Saudi J
Kidney Dis Transpl. 17:481–490. 2006.PubMed/NCBI
|
|
4
|
Zou J, Yu X, Qu S, Li X, Jin Y and Sui D:
Protective effect of total flavonoids extracted from the leaves of
Murraya paniculata (L.) Jack on diabetic nephropathy in rats. Food
Chem Toxicol. 64:231–237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gohda T, Mima A, Moon JY and Kanasaki K:
Combat diabetic nephropathy: From pathogenesis to treatment. J
Diabetes Res. 2014:2071402014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pan HZ, Zhang L, Guo MY, Sui H, Li H, Wu
WH, Qu NQ, Liang MH and Chang D: The oxidative stress status in
diabetes mellitus and diabetic nephropathy. Acta Diabetol. 47 Suppl
1:S71–S76. 2010. View Article : Google Scholar
|
|
7
|
Swaminathan S and Shah SV: Novel
approaches targeted toward oxidative stress for the treatment of
chronic kidney disease. Curr Opin Nephrol Hypertens. 17:143–148.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tabak O, Gelisgen R, Erman H, Erdenen F,
Muderrisoglu C, Aral H and Uzun H: Oxidative lipid, protein and DNA
damage as oxidative stress markers in vascular complications of
diabetes mellitus. Clin Invest Med. 34:E163–E171. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ho C, Lee PH, Hsu YC, Wang FS, Huang YT
and Lin CL: Sustained Wnt/β-catenin signaling rescues high glucose
induction of transforming growth factor-β1-mediated renal fibrosis.
Am J Med Sci. 344:374–382. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zorena K, Malinowska E, Raczyńska D,
Myśliwiec M and Raczyńska K: Serum concentrations of transforming
growth factor-Beta 1 in predicting the occurrence of diabetic
retinopathy in juvenile patients with type 1 diabetes mellitus. J
Diabetes Res. 2013:6149082013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen MM, Lam A, Abraham JA, Schreiner GF
and Joly AH: CTGF expression is induced by TGF-beta in cardiac
fibroblasts and cardiac myocytes: A potential role in heart
fibrosis. J Mol Cell Cardiol. 32:1805–1819. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li X, Cui X, Sun X, Li X, Zhu Q and Li W:
Mangiferin prevents diabetic nephropathy progression in
streptozotocin-induced diabetic rats. Phytother Res. 24:893–899.
2010.PubMed/NCBI
|
|
13
|
Nasri H and Rafieian-Kopaei M: Metformin:
Current knowledge. J Res Med Sci. 19:658–664. 2014.PubMed/NCBI
|
|
14
|
Kirpichnikov D, McFarlane SI and Sowers
JR: Metformin: An update. Ann Intern Med. 137:25–33. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Grossmann ME, Yang DQ, Guo Z, Potter DA
and Cleary MP: Metformin Treatment for the Prevention and/or
Treatment of Breast/Mammary Tumorigenesis. Curr Pharmacol Rep.
1:312–323. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rafieian-Kopaei M and Nasri H: Ginger and
diabetic nephropathy. J Renal Inj Prev. 2:9–10. 2013.PubMed/NCBI
|
|
17
|
Baradaran A: Lipoprotein(a), type 2
diabetes and nephropathy; the mystery continues. J Nephropathol.
1:126–129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim CS, Sohn EJ, Kim YS, Jung DH, Jang DS,
Lee YM, Kim DH and Kim JS: Effects of KIOM-79 on hyperglycemia and
diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats. J
Ethnopharmacol. 111:240–247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kong LL, Wu H, Cui WP, Zhou WH, Luo P, Sun
J, Yuan H and Miao LN: Advances in murine models of diabetic
nephropathy. J Diabetes Res. 2013:7975482013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dupuis F, Atkinson J, Limiñana P and
Chillon JM: Captopril improves cerebrovascular structure and
function in old hypertensive rats. Br J Pharmacol. 144:349–356.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Szkudelski T: The mechanism of alloxan and
streptozotocin action in B cells of the rat pancreas. Physiol Res.
50:537–546. 2001.PubMed/NCBI
|
|
22
|
Lenzen S: The mechanisms of alloxan- and
streptozotocin-induced diabetes. Diabetologia. 51:216–226. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hall-Craggs M, Brenner DE, Vigorito RD and
Sutherland JC: Acute renal failure and renal tubular squamous
metaplasia following treatment with streptozotocin. Hum Pathol.
13:597–601. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tay YC, Wang Y, Kairaitis L, Rangan GK,
Zhang C and Harris DC: Can murine diabetic nephropathy be separated
from superimposed acute renal failure? Kidney Int. 68:391–398.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang X, Ma H, Wang Y and Liu Y: Early
life factors and type 2 diabetes mellitus. J Diabetes Res.
2013:4850822013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee KM, Yang SJ, Kim YD, Choi YD, Nam JH,
Choi CS, Choi HS and Park CS: Disruption of the cereblon gene
enhances hepatic AMPK activity and prevents high-fat diet-induced
obesity and insulin resistance in mice. Diabetes. 62:1855–1864.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mogensen CE, Christensen CK and Vittinghus
E: The stages in diabetic renal disease. With emphasis on the stage
of incipient diabetic nephropathy. Diabetes. 32 Suppl 2:S64–S78.
1983. View Article : Google Scholar
|
|
28
|
Viberti G and Wheeldon NM;
MicroAlbuminuria Reduction With VALsartan (MARVAL) Study
Investigators, : Microalbuminuria reduction with valsartan in
patients with type 2 diabetes mellitus: A blood
pressure-independent effect. Circulation. 106:672–678. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang XL, Lu JM, Pan CY and Tian H: A study
comparing the prevalence of urinary albumin excretion and
microalbuminuria in pre-diabetes subjects. Zhonghua Nei Ke Za Zhi.
43:170–173. 2004.(In Chinese). PubMed/NCBI
|
|
30
|
Stirban A, Gawlowski T and Roden M:
Vascular effects of advanced glycation endproducts: Clinical
effects and molecular mechanisms. Mol Metab. 3:94–108. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sakai H, Jinde K, Suzuki D, Yagame M and
Nomoto Y: Localization of glycated proteins in the glomeruli of
patients with diabetic nephropathy. Nephrol Dial Transplant. 11
Suppl 5:S66–S71. 1996. View Article : Google Scholar
|
|
32
|
Rösen P, Nawroth PP, King G, Möller W,
Tritschler HJ and Packer L: The role of oxidative stress in the
onset and progression of diabetes and its complications: A summary
of a Congress Series sponsored by UNESCO-MCBN, the American
diabetes association and the german diabetes society. Diabetes
Metab Res Rev. 17:189–212. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Iwasaki Y, Sawada T, Kijima H, Kosuge T,
Katoh M, Rokkaku K, Kita J, Shimoda M and Kubota K: Estimated
glomerular filtration rate is superior to measured creatinine
clearance for predicting postoperative renal dysfunction in
patients undergoing pancreatoduodenectomy. Pancreas. 39:20–25.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yan LJ: Analysis of oxidative modification
of proteins. Curr Protoc Protein Sci Chapter. 14:Unit14.42009.
|
|
35
|
Booth AA, Khalifah RG, Todd P and Hudson
BG: In vitro kinetic studies of formation of antigenic advanced
glycation end products (AGEs). Novel inhibition of post-Amadori
glycation pathways. J Biol Chem. 272:5430–5437. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Miyoshi H, Taguchi T, Sugiura M, Takeuchi
M, Yanagisawa K, Watanabe Y, Miwa I, Makita Z and Koike T:
Aminoguanidine pyridoxal adduct is superior to aminoguanidine for
preventing diabetic nephropathy in mice. Horm Metab Res.
34:371–377. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wagener FA, Dekker D, Berden JH,
Scharstuhl A and van der Vlag J: The role of reactive oxygen
species in apoptosis of the diabetic kidney. Apoptosis.
14:1451–1458. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Singh DK, Winocour P and Farrington K:
Oxidative stress in early diabetic nephropathy: Fueling the fire.
Nat Rev Endocrinol. 7:176–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Krishan P and Chakkarwar VA: Diabetic
nephropathy: Aggressive involvement of oxidative stress. J Pharm
Educ Res. 2:352011.
|
|
40
|
Mima A: Inflammation and oxidative stress
in diabetic nephropathy: New insights on its inhibition as new
therapeutic targets. J Diabetes Res. 2013:2485632013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shao N, Kuang HY, Wang N, Gao XY, Hao M,
Zou W and Yin HQ: Relationship between oxidant/antioxidant markers
and severity of microalbuminuria in the early stage of Nephropathy
in type 2 diabetic Patients. J Diabetes Res. 2013:2324042013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Grover HS and Luthra S: Molecular
mechanisms involved in the bidirectional relationship between
diabetes mellitus and periodontal disease. J Indian Soc
Periodontol. 17:292–301. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Iacopino AM: Periodontitis and diabetes
interrelationships: Role of inflammation. Ann Periodontol.
6:125–137. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Howard BV: Lipoprotein metabolism in
diabetes mellitus. J Lipid Res. 28:613–628. 1987.PubMed/NCBI
|
|
45
|
Ma Y, Wang Y, Huang Q, Ren Q, Chen S,
Zhang A, Zhao L, Zhen Q and Peng Y: Impaired β cell function in
Chinese newly diagnosed type 2 diabetes mellitus with
hyperlipidemia. J Diabetes Res. 2014:4930392014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Moorhead JF, Chan MK, El-Nahas M and
Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular
and tubulo-interstitial disease. Lancet. 2:1309–1311. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Krolewski AS, Warram JH and Christlieb AR:
Hypercholesterolemia-a determinant of renal function loss and
deaths in IDDM patients with nephropathy. Kidney Int Suppl.
45:S125–S131. 1994.PubMed/NCBI
|
|
48
|
Ravid M, Neumann L and Lishner M: Plasma
lipids and the progression of nephropathy in diabetes mellitus type
II: Effect of ACE inhibitors. Kidney Int. 47:907–910. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rosario RF and Prabhakar S: Lipids and
diabetic nephropathy. Curr Diab Rep. 6:455–462. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lee HB, Yu MR, Yang Y, Jiang Z and Ha H:
Reactive oxygen species-regulated signaling pathways in diabetic
nephropathy. J Am Soc Nephrol. 14 8 Suppl 3:S241–S245. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Choudhary N and Ahlawat RS: Interleukin-6
and C-reactive protein in pathogenesis of diabetic nephropathy: New
evidence linking inflammation, glycemic control and
microalbuminuria. Iran J Kidney Dis. 2:72–79. 2008.PubMed/NCBI
|
|
52
|
Branchetti E, Poggio P, Sainger R, Shang
E, Grau JB, Jackson BM, Lai EK, Parmacek MS, Gorman RC, Gorman JH,
et al: Oxidative stress modulates vascular smooth muscle cell
phenotype via CTGF in thoracic aortic aneurysm. Cardiovasc Res.
100:316–324. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Vestra M Dalla, Mussap M, Gallina P,
Bruseghin M, Cernigoi AM, Saller A, Plebani M and Fioretto P:
Acute-phase markers of inflammation and glomerular structure in
patients with type 2 diabetes. J Am Soc Nephrol. 16 Suppl
1:S78–S82. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sekizuka K, Tomino Y, Sei C, Kurusu A,
Tashiro K, Yamaguchi Y, Kodera S, Hishiki T, Shirato I and Koide H:
Detection of serum IL-6 in patients with diabetic nephropathy.
Nephron. 68:284–285. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chen FQ, Wang J, Liu XB, Ma XY, Zhang XB,
Huang T, Ma DW and Wang QY: Levels of inflammatory cytokines in
type 2 diabetes patients with different urinary albumin excretion
rates and their correlation with clinical variables. J Diabetes
Res. 2013:1389692013. View Article : Google Scholar : PubMed/NCBI
|
